Migraine trials in Iran
1 trial · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 4RecruitingTrial-stage medicine
Evaluation of Efficacy and Safety of Topical Cannabidiol (Canvert-M Produced by Alasht Pharmed co. Iran) in the Treatment of Migraine Attacks
- Where
- Tehran
- Age
- 18 years to 55 years
- People
- 30
- Run by
- Alasht Pharmed
See details and how to joinNCT07093138Registry updated 2025-07-30
All Migraine trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.